Differences in the Use and Opinions About New eHealth Technologies Among Patients With Psychosis: Structured Questionnaire

[EN] Background: Despite a growing interest in the use of technology in order to support the treatment of psychotic disorders, limited knowledge exists about the viability and acceptability of these eHealth interventions in relation to the clinical characteristics of patients. Objective: The objective of this study was to assess the access and use of, as well as experiences and interest in, new technologies using a survey of patients diagnosed with early psychosis compared with a survey of patients diagnosed with chronic psychotic disorders. Methods: We designed a structured questionnaire. This questionnaire was divided into five parts: (1) clinical and demographic information, (2) access and use of the internet, (3) use of the internet in relation to mental health, (4) experiences with technology, and (5) patients¿ interest in eHealth services. In total, 105 patients were recruited from early psychosis units (n=65) and recovery units (n=40). Results: In this study, 84.8% (89/105) of the patients had access to the internet and 88.6% (93/105) owned an electronic internet device. In total, 71.3% (57/80) of patients who owned a mobile phone were interested in eHealth systems and 38.2% (37/97) reported negative experiences related to the internet usage. We observed differences between the groups in terms of device ownership (P=.02), the frequency of internet access (P<.001), the use of social media (P=.01), and seeking health information (P=.04); the differences were found to be higher in the early psychosis group. No differences were found between the groups in terms of the use of internet in relation to mental health, experiences and opinions about the internet, or interest in eHealth interventions (P=.43). Conclusions: The availability and use of technology for the participants in our survey were equivalent to those for the general population. The differences found between the groups in relation to the access or use of technology seemed to due to age-related factors. The use of technology involving mental health and the interest in eHealth interventions were mainly positive and equivalent between the groups. Accordingly, this group of patients is a potential target for the emerging eHealth interventions, regardless of their clinical status. However, 28.7% (23/80) of the studied patients rejected the use of internet interventions and 38.2% (37/97) had unpleasant experiences related to its usage; thus, more in-depth studies are needed to better define the profile of patients with psychosis who may benefit from eHealth treatments.This study was supported by Generalitat Valenciana (PROMETEO/2016/082 grant) and CIBERSAM and Fondo de Investigacion Sanitaria (PI01399, PI13/00447; PI17/00402, Cofunded FEDER).Bonet, L.; Llácer, B.; Hernandez-Viadel, M.; Arce Grilo, AD.; Blanquer Espert, I.; Cañete, C.; Escartí, MJ.... (2018). Differences in the Use and Opinions About New eHealth Technologies Among Patients With Psychosis: Structured Questionnaire. JMIR Mental Health. 5(3):1-12. https://doi.org/10.2196/mental.9950S11253Perkins, D. O., Gu, H., Boteva, K., & Lieberman, J. A. (2005). Relationship Between Duration of Untreated Psychosis and Outcome in First-Episode Schizophrenia: A Critical Review and Meta-Analysis. American Journal of Psychiatry, 162(10), 1785-1804. doi:10.1176/appi.ajp.162.10.1785Marshall, M., & Rathbone, J. (2011). Early intervention for psychosis. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.cd004718.pub3Amos, A. (2012). Assessing the cost of early intervention in psychosis: A systematic review. Australian & New Zealand Journal of Psychiatry, 46(8), 719-734. doi:10.1177/0004867412450470Bonet, L., Izquierdo, C., Escartí, M. J., Sancho, J. V., Arce, D., Blanquer, I., & Sanjuan, J. (2017). Utilización de tecnologías móviles en pacientes con psicosis: una revisión sistemática. Revista de Psiquiatría y Salud Mental, 10(3), 168-178. doi:10.1016/j.rpsm.2017.01.003World Health Organization2007Global Observatory for eHealth http://www.who.int/goe/en/Bucci, S., Barrowclough, C., Ainsworth, J., Morris, R., Berry, K., Machin, M., … Haddock, G. (2015). Using mobile technology to deliver a cognitive behaviour therapy-informed intervention in early psychosis (Actissist): study protocol for a randomised controlled trial. Trials, 16(1). doi:10.1186/s13063-015-0943-3Schlosser, D., Campellone, T., Kim, D., Truong, B., Vergani, S., Ward, C., & Vinogradov, S. (2016). Feasibility of PRIME: A Cognitive Neuroscience-Informed Mobile App Intervention to Enhance Motivated Behavior and Improve Quality of Life in Recent Onset Schizophrenia. JMIR Research Protocols, 5(2), e77. doi:10.2196/resprot.5450Garety, P. A., Ward, T., Freeman, D., Fowler, D., Emsley, R., Dunn, G., … Hardy, A. (2017). SlowMo, a digital therapy targeting reasoning in paranoia, versus treatment as usual in the treatment of people who fear harm from others: study protocol for a randomised controlled trial. Trials, 18(1). doi:10.1186/s13063-017-2242-7Depp, C. A., Harmell, A. L., Vahia, I. V., & Mausbach, B. T. (2015). Neurocognitive and functional correlates of mobile phone use in middle-aged and older patients with schizophrenia. Aging & Mental Health, 20(1), 29-35. doi:10.1080/13607863.2015.1008987National Alliance on Mental Illness (NAMI)2017-10-10Health and Technology Study 2014https://www.nami.org/About-NAMI/Publications-Reports/Survey-Reports/Health-and-Technology-Study-(2014)SmithAThe Smartphone difference: U.S. Smartphone Use in2015Washington, DCPew Research Centrehttp://www.pewinternet.org/2015/04/01/us-smartphone-use-in-2015Tobitt, S., & Percival, R. (2017). Switched on or switched off? A survey of mobile, computer and Internet use in a community mental health rehabilitation sample. Journal of Mental Health, 28(1), 4-10. doi:10.1080/09638237.2017.1340623Firth, J., Cotter, J., Torous, J., Bucci, S., Firth, J. A., & Yung, A. R. (2015). Mobile Phone Ownership and Endorsement of «mHealth» Among People With Psychosis: A Meta-analysis of Cross-sectional Studies. Schizophrenia Bulletin, 42(2), 448-455. doi:10.1093/schbul/sbv132Thomas, N., Foley, F., Lindblom, K., & Lee, S. (2017). Are people with severe mental illness ready for online interventions? Access and use of the Internet in Australian mental health service users. Australasian Psychiatry, 25(3), 257-261. doi:10.1177/1039856217689913Gitlow, L., Abdelaal, F., Etienne, A., Hensley, J., Krukowski, E., & Toner, M. (2017). Exploring the Current Usage and Preferences for Everyday Technology among People with Serious Mental Illnesses. Occupational Therapy in Mental Health, 33(1), 1-14. doi:10.1080/0164212x.2016.1211061Trefflich, F., Kalckreuth, S., Mergl, R., & Rummel-Kluge, C. (2015). Psychiatric patients׳ internet use corresponds to the internet use of the general public. Psychiatry Research, 226(1), 136-141. doi:10.1016/j.psychres.2014.12.037Gay, K., Torous, J., Joseph, A., Pandya, A., & Duckworth, K. (2016). Digital Technology Use Among Individuals with Schizophrenia: Results of an Online Survey. JMIR Mental Health, 3(2), e15. doi:10.2196/mental.5379Berry, N., Lobban, F., Emsley, R., & Bucci, S. (2016). Acceptability of Interventions Delivered Online and Through Mobile Phones for People Who Experience Severe Mental Health Problems: A Systematic Review. Journal of Medical Internet Research, 18(5), e121. doi:10.2196/jmir.5250Birnbaum, M. L., Rizvi, A. F., Correll, C. U., Kane, J. M., & Confino, J. (2015). Role of social media and the Internet in pathways to care for adolescents and young adults with psychotic disorders and non-psychotic mood disorders. Early Intervention in Psychiatry, 11(4), 290-295. doi:10.1111/eip.12237Ben-Zeev, D., Scherer, E. A., Gottlieb, J. D., Rotondi, A. J., Brunette, M. F., Achtyes, E. D., … Kane, J. M. (2016). mHealth for Schizophrenia: Patient Engagement With a Mobile Phone Intervention Following Hospital Discharge. JMIR Mental Health, 3(3), e34. doi:10.2196/mental.6348Kannisto, K. A., Adams, C. E., Koivunen, M., Katajisto, J., & Va lima ki, M. (2015). Feedback on SMS reminders to encourage adherence among patients taking antipsychotic medication: a cross-sectional survey nested within a randomised trial. BMJ Open, 5(11), e008574-e008574. doi:10.1136/bmjopen-2015-008574Instituto Nacional de EstadísticaEncuesta sobre equipamiento y uso de tecnologías de información y comunicación en los hogares2016 http://www.ine.es/dyngs/INEbase/es/operacion.htm?c=Estadistica_C&cid=1254736176741&menu=ultiDatos&idp=1254735976608Robotham, D., Satkunanathan, S., Doughty, L., & Wykes, T. (2016). Do We Still Have a Digital Divide in Mental Health? A Five-Year Survey Follow-up. Journal of Medical Internet Research, 18(11), e309. doi:10.2196/jmir.6511Miller, B. J., Stewart, A., Schrimsher, J., Peeples, D., & Buckley, P. F. (2015). How connected are people with schizophrenia? Cell phone, computer, email, and social media use. Psychiatry Research, 225(3), 458-463. doi:10.1016/j.psychres.2014.11.067Borzekowski, D. L. G., Leith, J., Medoff, D. R., Potts, W., Dixon, L. B., Balis, T., … Himelhoch, S. (2009). Use of the Internet and Other Media for Health Information Among Clinic Outpatients With Serious Mental Illness. Psychiatric Services, 60(9), 1265-1268. doi:10.1176/ps.2009.60.9.1265Aref-Adib, G., O’Hanlon, P., Fullarton, K., Morant, N., Sommerlad, A., Johnson, S., & Osborn, D. (2016). A qualitative study of online mental health information seeking behaviour by those with psychosis. BMC Psychiatry, 16(1). doi:10.1186/s12888-016-0952-0Baup, H., & Verdoux, H. (2017). Frequency and pattern of Internet use in patients with schizophrenia or bipolar disorders seeking medical information. Psychiatry Research, 247, 152-154. doi:10.1016/j.psychres.2016.11.028Digital Marketing Trends (DiTrendia)MT(Informe mobile en España y en el mundo20162018-07-122016 http://www.amic.media/media/files/file_352_1050.pdfLal, S., Dell’Elce, J., Tucci, N., Fuhrer, R., Tamblyn, R., & Malla, A. (2015). Preferences of Young Adults With First-Episode Psychosis for Receiving Specialized Mental Health Services Using Technology: A Survey Study. JMIR Mental Health, 2(2), e18. doi:10.2196/mental.4400Schrank, B., Sibitz, I., Unger, A., & Amering, M. (2010). How Patients With Schizophrenia Use the Internet: Qualitative Study. Journal of Medical Internet Research, 12(5), e70. doi:10.2196/jmir.1550Asociaciónpara la Investigación de Medios de Comunicación (AIMC)Encuesta AIMC a usuarios de internet2017-10-192017 http://www.aimc.es/-Navegantes-en-la-Red-.htmlNowland, R., Necka, E. A., & Cacioppo, J. T. (2017). Loneliness and Social Internet Use: Pathways to Reconnection in a Digital World? Perspectives on Psychological Science, 13(1), 70-87. doi:10.1177/1745691617713052Heinz, A., Deserno, L., & Reininghaus, U. (2013). Urbanicity, social adversity and psychosis. World Psychiatry, 12(3), 187-197. doi:10.1002/wps.20056Alvarez-Jimenez, M., Priede, A., Hetrick, S. E., Bendall, S., Killackey, E., Parker, A. G., … Gleeson, J. F. (2012). Risk factors for relapse following treatment for first episode psychosis: A systematic review and meta-analysis of longitudinal studies. Schizophrenia Research, 139(1-3), 116-128. doi:10.1016/j.schres.2012.05.007Berry, N., Bucci, S., & Lobban, F. (2017). Use of the Internet and Mobile Phones for Self-Management of Severe Mental Health Problems: Qualitative Study of Staff Views. JMIR Mental Health, 4(4), e52. doi:10.2196/mental.8311Bhugra, D., Tasman, A., Pathare, S., Priebe, S., Smith, S., Torous, J., … Ventriglio, A. (2017). The WPA- Lancet Psychiatry Commission on the Future of Psychiatry. The Lancet Psychiatry, 4(10), 775-818. doi:10.1016/s2215-0366(17)30333-4Lachmann, B., Sindermann, C., Sariyska, R. Y., Luo, R., Melchers, M. C., Becker, B., … Montag, C. (2018). The Role of Empathy and Life Satisfaction in Internet and Smartphone Use Disorder. Frontiers in Psychology, 9. doi:10.3389/fpsyg.2018.00398Stodt, B., Brand, M., Sindermann, C., Wegmann, E., Li, M., Zhou, M., … Montag, C. (2018). Investigating the Effect of Personality, Internet Literacy, and Use Expectancies in Internet-Use Disorder: A Comparative Study between China and Germany. International Journal of Environmental Research and Public Health, 15(4), 579. doi:10.3390/ijerph1504057

A Proteomics Approach To Quantify Protein Levels Following RNA Interference:Case Study with Glutathione Transferase Superfamily from the Model Metazoan Caenorhabditis elegans

Loss-of-function phenotypic analysis via interference RNA (RNAi) technology is a revolutionary approach to assigning gene function. While transcript-based methodologies commonly validate RNAi gene suppression investigations, protein-based validation is less developed. This report illustrates the potential for two-dimensional sodium dodecyl sulfate polyacrylamide gel electrophoresis (2-DE) and gel analysis to quantify protein levels following RNAi. This case study involves three glutathione transferase (GST) genes targeted by RNAi from the model organism Caenorhabditis elegans

In vivo exposure to carbon monoxide induces delayed soluble guanylate cyclase activation by nitric oxide in rat brain cortex and cerebellum

In rats, both acute and chronic exposure to carbon monoxide altered the activity of guanylate cyclase and its modulation by nitric oxide in brain cortex and cerebellum

Lymphocyte cytochrome c oxidase, cyclic GMP and cholinergic muscarinic receptors as peripheral indicators of carbon monoxide neurotoxicity after acute and repeated exposure in the rat

Changes in cerebral cytochrome oxidase (COX) activity, nitric oxide (NO)–cyclic GMP (cGMP) pathway and cholinergic muscarinic receptors (MRs) have been reported in rodents acutely exposed to carbon monoxide (CO). These endpoints measurable in lymphocytes may serve as peripheral markers of CO neurotoxicity. The early and delayed effects of repeated and acute in vivo CO inhalation were investigated on COX activity, cGMP formation and MR binding in rat brain and lymphocytes to assess whether each endpoint was similarly affected both centrally and peripherally. Male Wistar rats either inhaled 500 ppm CO, 6 h/day, 5 days/week, 4 weeks (repeated exposure) or 2400 ppm, 1 h (single exposure). Neither treatment altered brain or lymphocyte COX activity 1 and 7 days post-treatment. Also ineffective were repeated and acute CO treatments towards 3H-quinuclidinyl benzilate (QNB) binding to MRs in cerebral cortex, hippocampus, striatum, cerebellum (respective controls, meanTS.D.: 171T45, 245T53, 263T14 and 77T7 fmol/mg protein) and lymphocytes (24T10 fmol/million cells) at the same time points. In lymphocytes control cGMP levels averaged 1.98T0.99 pmol/mg protein under basal conditions, and 3.94T0.55 pmol/mg protein after NO-stimulation. One day after chronic treatment cessation, the CO-treated group displayed about a 50% decrease in both basal and NOstimulated cGMP values, which persisted up to 7 days after, compared to air-exposed rats. Acutely, CO caused a delayed enhancement (+140%) of NO-induced activation of soluble guanylate cyclase. The finding that the NO–cGMP pathway is a target for the delayed effects of CO in peripheral blood cells is in accordance with our data in brain. In vivo exposure to carbon monoxide causes delayed impairment of activation of soluble guanylate cyclase by nitric oxide in rat brain cortex and cerebellum

Extracellular cGMP Modulates Learning Biphasically by Modulating Glycine Receptors, CaMKII and Glutamate-Nitric Oxide-cGMP Pathway

It has been proposed that extracellular cGMP modulates the ability to learn a Y maze task, but the underlying mechanisms remained unknown. Here we show that extracellular cGMP, at physiological concentrations, modulates learning in the Y maze in a biphasic way by modulating the glutamate-nitric oxide-cGMP pathway in cerebellum. Extracellular cGMP reduces glycine receptors activation inducing a voltage-dependent calcium-channels-mediated increase of calcium in Purkinje neurons. This calcium increase modulates CaMKII phosphorylation in a biphasic way. When basal calcium concentration is low extracellular cGMP reduces CaMKII phosphorylation, increasing nitric oxide synthase activity, the glutamate-NO-cGMP pathway function and learning ability. When basal calcium is normal extracellular cGMP increases CaMKII phosphorylation, reducing nitric oxide synthase activity, the pathway function and learning. These data unveil new mechanisms modulating learning in the Y maze and likely other learning types which may be therapeutic targets to improve learning in pathological situations associated with altered cGMP levels